It's definitely not FDA. Probably people seeing a reversal in global markets and don't want to miss out on the buying opportunity. But it could also be the Sanofi partnership, 5 days to go!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
